An ethical framework for public health immunisation programs
David Isaacs
+ Author Affiliations
- Author Affiliations
Department of Infectious Diseases, Children’s Hospital at Westmead
Email: david.isaacs@health.nsw.gov.au
NSW Public Health Bulletin 23(6) 111-115 https://doi.org/10.1071/NB11045
Published: 28 June 2012
Abstract
This paper presents seven ethical principles associated with the implementation of immunisation programs. For a public health immunisation program to be ethically justifiable, its principles and operation should be based on sound ethical values: the program should benefit the individual and the community; targeted diseases should be sufficiently severe and frequent to justify the risks and expense of the program, and vulnerable groups within the population should be targeted. The principles also deal with the obligation to monitor for adverse events and for disease incidence to ensure safety and effectiveness. When immunisations are voluntary, vaccine recipients or their parents or carers should be given sufficient information to make autonomous, informed decisions and incentives to participate in public health immunisation programs should not be coercive. Public health immunisation programs depend on mutual trust, which may be threatened by circumstances such as excessive media publicity about adverse events associated with vaccines.
References
[1] Ada G, Isaacs D. Vaccination, the facts, the fears, the future. Sydney: Allen & Unwin; 2000.[2] Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008; 86 140–6.
| Vaccination greatly reduces disease, disability, death and inequity worldwide.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1c7kt1Srtg%3D%3D&md5=a4742fe3b45a15a4da463b2822e6668fCAS |
[3] Vitek CR, Wharton M. Diphtheria in the former Soviet Union: re-emergence of a pandemic disease. Emerg Infect Dis 1998; 4 539–50.
| Diphtheria in the former Soviet Union: re-emergence of a pandemic disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M%2Fotl2lsA%3D%3D&md5=0593ad58f7dc42c3f1a511b24942344cCAS |
[4] Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336 1855–9.
| Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2szisVSlsw%3D%3D&md5=c4414920ce10b3b92b365f8f1445eb83CAS |
[5] Brotherton JML, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination program on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377 2085–92.
| Early effect of the HPV vaccination program on cervical abnormalities in Victoria, Australia: an ecological study.Crossref | GoogleScholarGoogle Scholar |
[6] Verweij M, Dawson A. Ethical principles for collective immunisation programs. Vaccine 2004; 22 3122–6.
| Ethical principles for collective immunisation programs.Crossref | GoogleScholarGoogle Scholar |
[7] Diekema DS. American Academy of Pediatrics Committee on Bioethics Responding to parental refusals of immunization of children. Pediatrics 2005; 115 1428–31.
| Responding to parental refusals of immunization of children.Crossref | GoogleScholarGoogle Scholar |
[8] Leask J, Braunack-Mayer A, Kerridge I. Consent and public engagement in an era of expanded childhood immunisation. J Paediatr Child Health 2011; 47 603–7.
| Consent and public engagement in an era of expanded childhood immunisation.Crossref | GoogleScholarGoogle Scholar |
[9] Beall B. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting. Expert Rev Vaccines 2007; 6 297–300.
| Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXmtVGitrY%3D&md5=3c8260ddff42e2a3cc30714ebadccbdfCAS |
[10] Australian Government Department of Health and Ageing. Pharmaceutical Benefits Scheme. Available at: http://www.pbs.gov.au/pbs/home (Cited 1 October 2011).
[11] Isaacs D, Kilham HA, Marshall H. Should routine childhood immunizations be compulsory? J Paediatr Child Health 2004; 40 392–6.
| Should routine childhood immunizations be compulsory?Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2czltFyrtw%3D%3D&md5=e131489b9de7fc765065e108814ea54aCAS |
[12] Papavasiliou A, Stanton J, Sinha P, Forder J, Skyrme A. The complexity of seat belt injuries including spinal injury in the pediatric population: a case report of a 6-year-old boy and the literature review. Eur J Emerg Med 2007; 14 180–3.
| The complexity of seat belt injuries including spinal injury in the pediatric population: a case report of a 6-year-old boy and the literature review.Crossref | GoogleScholarGoogle Scholar |
[13] Isaacs D, Leask J. Should influenza immunisation be compulsory for health care workers? No. BMJ 2008; 337 a2140
| Should influenza immunisation be compulsory for health care workers? No.Crossref | GoogleScholarGoogle Scholar |
[14] Helms CM, Polgreen PM. Should influenza immunisation be compulsory for health care workers? Yes. BMJ 2008; 337 a2142
| Should influenza immunisation be compulsory for health care workers? Yes.Crossref | GoogleScholarGoogle Scholar |
[15] Isaacs D. Children have rights, too. J Paediatr Child Health 2009; 45 627–8.
| Children have rights, too.Crossref | GoogleScholarGoogle Scholar |
[16] Isaacs D, Kilham HA, Alexander S, Wood N, Buckmaster A, Royle J. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine 2011; 29 6159–62.
| Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation.Crossref | GoogleScholarGoogle Scholar |
[17] American Academy of Pediatrics Religious objections to medical care. Pediatrics 1997; 99 279–81.
| Religious objections to medical care.Crossref | GoogleScholarGoogle Scholar |
[18] Kelly HA, Looker C, Isaacs D. A no-fault compensation scheme for serious adverse events attributed to vaccination. Med J Aust 2011; 195 4–5.
[19] Watson CR, Plant AJ. Medical misadventure, indemnity and public health. Aust J Public Health 1993; 17 88–90.
| Medical misadventure, indemnity and public health.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2c%2Fgt1KjsA%3D%3D&md5=268c091f30386087a47b70e1e2676297CAS |
[20] Centers for Disease Control and Prevention Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral polio-virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). [Erratum in: MMWR Morb Mortal Wkly Rep 1997 Feb 28; 46][8]:183 MMWR Recomm Rep 1997; 46 1–25.
[21] Tucker AW, Isaacs D, Burgess M. Cost-effectiveness analysis of changing from live oral polio virus vaccine to inactivated polio virus vaccine in Australia. Aust N Z J Public Health 2001; 25 411–6.
| 1:STN:280:DC%2BD3MnjsFeqtA%3D%3D&md5=4113bbc0d3b13d464ca84066f9d90a04CAS |
[22] Marshall H, Ryan P, Roberton D, Baghurst P. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Health 2007; 31 235–42.
| A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine.Crossref | GoogleScholarGoogle Scholar |
